Mid-Day Breakouts Report - Friday, July 15th, 2022

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Friday, February 23, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - FRIDAY, JULY 15TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 31181.18 551.01 (1.80%) | NASDAQ 11386.86 135.67 (1.21%) | S&P 500 3846.99 56.61 (1.49%)

Time of Screening : 7/15/2022 12:30:10 PM Report Released : 7/15/2022 1:06:01 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AMN - NYSE - Comml Svcs-Staffing A M N Healthcare Svcs	$118.42	+0.98 0.83%	$119.74	$129.12	-8.29%	436,879 61.27%	713,000
Most Recent Note for AMN - 7/15/2022 12:31:41 PM Approaching its 52-week high with today's 2nd consecutive volume-driven gain. Recently rebounded above its 50 and 200 DMA lines. Reported Mar '22 quarterly earnings +105% on +75% sales revenues versus the year ago period, its 5th strong quarter versus the year ago period. Annual earnings (A criteria) growth had a downturn on FY '19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AZN - NYSE - DRUGS - Drug Manufacturers - Major Astrazeneca Plc Ads	$66.61	+1.53 2.34%	$66.96	$71.70	-7.11%	5,116,898 74.45%	6,873,000
Most Recent Note for AZN - 7/15/2022 12:32:24 PM Finding support near its 50 DMA line with today's gain. Little resistance remains due to overhead supply up to the $71 level. Prior mid-day reports noted - "Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CCRN - NASDAQ - DIVERSIFIED SERVICES - Staffing & Outsourcing Service Cross Country Healthcare	$26.83	+1.83 7.32%	$27.13	$30.40	-11.74%	513,309 111.83%	459,000
Most Recent Note for CCRN - 7/15/2022 12:37:14 PM Rebounding toward its 52-week high with today's volume-driven gain adding to a recent spurt. It has not formed a sound base, and faces a little resistance up to the $30 area. Recent quarterly comparisons through Mar '22 versus the year ago period showed strong sales revenues and earnings increases. Annual earnings growth (A criteria) has been strong since a downturn in FY '17 and '18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CLFD - NASDAQ - TELECOMMUNICATIONS - Cables / Satalite Equipment Clearfield Inc	$74.61	+0.62 0.84%	$75.71	$86.71	-13.95%	90,389 64.11%	141,000
Most Recent Note for CLFD - 7/15/2022 12:40:09 PM Has not formed a sound base and still faces some resistance up to the $86.71 level. Showed resilience and gradually rebounded since dropped from the Featured Stocks list on 1/19/22. Fundamentals remain strong after it reported Mar '22 quarterly earnings +144% on +80% sales revenues above the year ago period.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ECPG - NASDAQ - FINANCIAL SERVICES - Credit Services Encore Capital Group Inc	$64.89	+0.87 1.36%	$65.09	$72.67	-10.71%	177,568 57.65%	308,000
Most Recent Note for ECPG - 7/15/2022 12:41:10 PM Today's gain is adding to recent volume-driven gains. Prior mid-day reports cautioned members - "Reported the Mar '22 quarter with strong +115% earnings on +20% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
EVOP - NASDAQ - Finance-CrdtCard/PmtPr Evo Payments Inc	$26.23	+1.44 5.79%	$26.43	$29.95	-12.44%	510,212 181.57%	281,000
Most Recent Note for EVOP - 7/15/2022 12:45:51 PM Challenging prior highs with today's gain adding to recent volume-driven gains, but it faces resistance due to overhead supply up to the $31 level. Reported strong earnings increases in the 4 latest quarterly comparisons through Mar '22 versus the year ago periods. Annual earnings (A criteria) had a downturn in FY '20. Completed its $16 IPO on 5/23/18 and additional Public Offerings on 9/20/18 and 4/03/19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GSK - NYSE - Medical-Diversified Glaxosmithkline Plc Adr	$40.79	+0.57 1.42%	$41.00	$46.97	-13.16%	4,733,907 77.14%	6,137,000
Most Recent Note for GSK - 7/15/2022 12:46:33 PM Slumped well below its 200 DMA line with 5 consecutive losses. Recently met resistance near its 50 DMA line. Prior mid-day reports noted - "UK-based pharmaceuticals firm's quarterly comparisons through Mar '22 have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HUM - NYSE - HEALTH SERVICES - Health Care Plans Humana Inc	$487.26	+14.66 3.10%	$488.75	$490.77	-0.72%	542,400 66.80%	812,000
Most Recent Note for HUM - 7/15/2022 12:53:27 PM Gapped up today challenging its all-time high, on track for its 4th consecutive weekly gain. Quarterly comparisons through Mar '22 were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IMKTA - NASDAQ - RETAIL - Grocery Stores Ingles Markets Inc Cl A	$90.50	+0.60 0.67%	$91.68	$101.98	-11.26%	64,421 60.21%	107,000
Most Recent Note for IMKTA - 7/15/2022 1:01:19 PM Faces some resistance due to overhead supply up to the $101 level. Consolidating above its 50 DMA line ($89) after finding support at its 200 DMA line since dropped from the Featured Stocks list on 5/20/22. Reported Mar '22 quarterly earnings +40% on +16% sales revenues versus the year ago period.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
OBCI - NASDAQ - CONSUMER NON-DURABLES - Cleaning Products Ocean Bio Chem Inc	$12.93	+0.03 0.19%	$12.93	$13.40	-3.54%	34,993 87.48%	40,000
Most Recent Note for OBCI - 7/15/2022 1:01:58 PM Gapped up on 6/22/22 following M&A news. Fundamental concerns remain. Noted with caution in prior mid-day reports - "Sales revenues growth and earnings history is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
STZ - NYSE - FOOD & BEVERAGE - Beverages - Wineries & Distill Constellation Brands A	$244.50	-6.47 -2.58%	$246.10	$261.53	-6.51%	967,432 86.77%	1,115,000
Most Recent Note for STZ - 7/15/2022 1:04:53 PM Huge New York-based Beverages - Alcoholic firm found support near its 200 DMA line and is consolidating above its 50 DMA line ($242). Faces resistance due to overhead supply up to the $261 level. Reported earnings +14% on +17% sales revenues for the May '22 quarter versus the year ago period. Fundamental concerns remain due to sub par sales revenues growth and earnings in prior quarterly comparisons not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth had a slight downturn in FY '20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UNH - NYSE - HEALTH SERVICES - Health Care Plans Unitedhealth Group Inc	$529.04	+26.61 5.30%	$530.75	$553.29	-4.38%	2,406,967 68.89%	3,494,000
Most Recent Note for UNH - 7/15/2022 1:05:55 PM Gapped up today while consolidating above its 50 DMA line ($494). Prior mid-day reports cautioned members - "Reported earnings +3% on +14% sales revenues for the quarter ended March 31, 2022 versus the year ago period. Prior comparisons were erratic, not strong and steady above the +25% minimum guideline (C criteria). Annual earnings growth has been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.